BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16627903)

  • 1. Prolonged coma from refractory status epilepticus.
    Dara SI; Tungpalan LA; Manno EM; Lee VH; Moder KG; Keegan MT; Fulgham JR; Brown DR; Berge KH; Whalen FX; Roy TK
    Neurocrit Care; 2006; 4(2):140-2. PubMed ID: 16627903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment.
    Beretta S; Coppo A; Bianchi E; Zanchi C; Carone D; Stabile A; Padovano G; Sulmina E; Grassi A; Bogliun G; Foti G; Ferrarese C; Pesenti A; Beghi E; Avalli L
    Epilepsy Behav; 2019 Dec; 101(Pt B):106374. PubMed ID: 31300383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Refractory status epilepticus in children: characterisation of epilepsies, continuous electroencephalographic monitoring and response to treatment].
    Cardoso I; Acevedo K; Hernández M; Santin J; Moya P; Godoy J; Castillo A; Soto P; Mesa T
    Rev Neurol; 2013 Apr; 56(8):401-8. PubMed ID: 23568682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory status epilepticus: new insights in presentation, treatment, and outcome.
    Hocker S; Wijdicks EF; Rabinstein AA
    Neurol Res; 2013 Mar; 35(2):163-8. PubMed ID: 23336320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment.
    Beretta S; Coppo A; Bianchi E; Zanchi C; Carone D; Stabile A; Padovano G; Sulmina E; Grassi A; Bogliun G; Foti G; Ferrarese C; Pesenti A; Beghi E; Avalli L
    Neurology; 2018 Dec; 91(23):e2153-e2162. PubMed ID: 30381366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged refractory status epilepticus following acute traumatic brain injury: a case report of excellent neurological recovery.
    Peets AD; Berthiaume LR; Bagshaw SM; Federico P; Doig CJ; Zygun DA
    Crit Care; 2005; 9(6):R725-8. PubMed ID: 16280070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus.
    Kang BS; Jung KH; Shin JW; Moon JS; Byun JI; Lim JA; Moon HJ; Kim YS; Lee ST; Chu K; Lee SK
    J Clin Neurosci; 2015 May; 22(5):854-8. PubMed ID: 25744078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good outcome is possible after months of refractory convulsive status epilepticus: lesson learned.
    Standley K; Abdulmassih R; Benbadis S
    Epilepsia; 2012 Jan; 53(1):e17-20. PubMed ID: 22126230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus.
    Nagase H; Nishiyama M; Nakagawa T; Fujita K; Saji Y; Maruyama A
    Pediatr Neurol; 2014 Jul; 51(1):78-84. PubMed ID: 24830769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Young Man With Recurrent Coma and Refractory Status Epilepticus.
    Sheikh Z; Wang W; Hillen M
    JAMA Neurol; 2016 Oct; 73(10):1243-1244. PubMed ID: 27479548
    [No Abstract]   [Full Text] [Related]  

  • 20. Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes.
    Khawaja AM; Vines BL; Miller DW; Szaflarski JP; Amara AW
    Epileptic Disord; 2016 Mar; 18(1):34-43. PubMed ID: 26878120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.